MykoTech was established in 2002. The company is setting up a large culture collection of fungi and bacteria with the aim of exploring for nutraceuticals, pharmaceuticals and enzymes that will improve human health and environment. The company specializes in culturing microorganisms from rare and novel environments and screening them for various biotechnology products.  The present activities centre around filamentous fungi and yeasts, of which more than 1000 rare species are represented in its collection. These have been isolated from forest litter, endophytes, various plant materials, animal excreta and the sea.  MykoTech is gradually expanding its culture collection to include rare bacteria. The laboratory and office are situated in Goa, in the middle of the terrestrial hot spot of biodiversity and adjacent to the wealth of marine life.

The expertise:

·        Novel isolation techniques

·        Identification of fungi

·        Biodiversity of terrestrial, freshwater and marine ecosystems

·        Screening for nutraceuticals and pharmaceuticals

·        Industrial enzymes

Research Targets:

Establishment of a microbial culture collection:  

The primary task of the company is the establishment of a microbial culture collection par excellence.  Presently, rare and novel fungi are being isolated from a variety of terrestrial and marine ecosystems. 


Microbial metabolites research: 

MykoTech carries out screening of its microbial cultures for the following:

·     Nutraceutical compounds

·     Pharmaceutical compounds

·     Industrial enzymes

·     Bioremediation

·     Cosmetics

·     Biofuel

·     Industrial intermediates

Business Model

MykoTech is in the process of developing several technologies. The company will license out or sell some of its technologies to companies that are interested in manufacturing them. One of the major aims of the company is to establish a compound library of fungal extracts for discovery of bioactive molecules. The company offers consultancy in the area of fungal biodiversity and biotechnology.

Collaborative research: 

The company plans to establish collaborative research with other research institutions on biotechnology of fungi and bacteria. It will enter into MoUs for the purpose and shall take viable laboratory-scale technologies available at the various institutions to pilot-scale levels and subsequently to commercial levels. 

The R & D unit of Myko Tech has been accorded recognition by the Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Government of India with effect from 2 November 2007.